Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does GOLIMUMAB Cause Therapeutic product effect decreased? 5,478 Reports in FDA Database

Grow Your Own Natural Pharmacy at Home

Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.

Get the Kit

According to the FDA Adverse Event Reporting System (FAERS), 5,478 reports of Therapeutic product effect decreased have been filed in association with GOLIMUMAB (SIMPONI ARIA). This represents 7.9% of all adverse event reports for GOLIMUMAB.

5,478
Reports of Therapeutic product effect decreased with GOLIMUMAB
7.9%
of all GOLIMUMAB reports
911
Deaths
1,872
Hospitalizations

How Dangerous Is Therapeutic product effect decreased From GOLIMUMAB?

Of the 5,478 reports, 911 (16.6%) resulted in death, 1,872 (34.2%) required hospitalization, and 1,179 (21.5%) were considered life-threatening.

Is Therapeutic product effect decreased Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for GOLIMUMAB. However, 5,478 reports have been filed with the FAERS database.

What Other Side Effects Does GOLIMUMAB Cause?

Drug ineffective (17,959) Rheumatoid arthritis (12,272) Pain (11,443) Fatigue (9,626) Off label use (8,764) Alopecia (8,394) Rash (8,331) Joint swelling (8,264) Arthralgia (7,968) Abdominal discomfort (7,902)

What Other Drugs Cause Therapeutic product effect decreased?

ADALIMUMAB (11,058) METHOTREXATE (8,952) ETANERCEPT (8,819) ABATACEPT (7,256) TOCILIZUMAB (7,208) LEFLUNOMIDE (7,025) HYDROXYCHLOROQUINE (6,450) INFLIXIMAB (6,401) RITUXIMAB (6,281) SULFASALAZINE (5,386)

Which GOLIMUMAB Alternatives Have Lower Therapeutic product effect decreased Risk?

GOLIMUMAB vs GOLODIRSEN GOLIMUMAB vs GONADORELIN GOLIMUMAB vs GONADOTROPHIN, CHORIONIC GOLIMUMAB vs GOSERELIN GOLIMUMAB vs GRAMICIDIN

Related Pages

GOLIMUMAB Full Profile All Therapeutic product effect decreased Reports All Drugs Causing Therapeutic product effect decreased GOLIMUMAB Demographics